Brainstorm Stock Today

Equity ratings for Brainstorm Cell are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of June 2020 and ending today, the 29th of May 2022. Click here to learn more.
Brainstorm Cell cannot be verified against its exchange. It appears that Brainstorm Cell is not available for investing at the moment. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.

Brainstorm Cell Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Brainstorm Cell's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Brainstorm Cell or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Brainstorm Cell is not yet fully synchronised with the market data
Brainstorm Cell has some characteristics of a very speculative penny stock
Brainstorm Cell has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (24.46 M) with profit before overhead, payroll, taxes, and interest of 0.
Brainstorm Cell currently holds about 22.09 M in cash with (26.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.61.
Brainstorm Cell has a very weak financial position based on the latest SEC disclosures
Roughly 23.0% of the company shares are held by company insiders
Brainstorm Cell Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Brainstorm Cell SEC Filings
Brainstorm Cell SEC Filings Security & Exchange Commission EDGAR Reports
CEO and PresChaim Lebovits  (View All)
Thematic Classification
Currently Active Investing Idea (view all)
Pharmaceutical Products
Average Analyst Recommendation
Analysts covering Brainstorm Cell report their recommendations after researching Brainstorm Cell's financial statements, talking to executives and customers, or listening in on Brainstorm Cell's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Brainstorm Cell. The Brainstorm consensus assessment is calculated by taking the average forecast from all of the analysts covering Brainstorm Cell.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Brainstorm Cell based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Brainstorm Cell financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 1 - Very WeakDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares29.9 M36.2 M
Significantly Down
Slightly volatile
Weighted Average Shares Diluted29.9 M36.2 M
Significantly Down
Slightly volatile
Total Assets23.8 M29.3 M
Significantly Down
Slightly volatile
Total Liabilities8.8 M9.9 M
Fairly Down
Slightly volatile
Current Assets19.5 M23.3 M
Fairly Down
Slightly volatile
Current Liabilities6.4 M6.3 M
Slightly Up
Slightly volatile
Total Debt5.5 M5.1 M
Significantly Up
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Brainstorm Cell's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong HoldUndervalued
Financial Strength
Brainstorm Cell's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Brainstorm Cell's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Brainstorm Cell's financial leverage. It provides some insight into what part of Brainstorm Cell's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Brainstorm Cell's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Brainstorm Cell deploys its capital and how much of that capital is borrowed.
Brainstorm Cell cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 5.08 M in liabilities with Debt to Equity (D/E) ratio of 0.26, which may suggest the company is not taking enough advantage from borrowing. Brainstorm Cell has a current ratio of 3.61, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Brainstorm Cell until it has trouble settling it off, either with new capital or with free cash flow. So, Brainstorm Cell's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Brainstorm Cell sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Brainstorm to invest in growth at high rates of return. When we think about Brainstorm Cell's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

(26.96 Million)Share
Brainstorm Cell (BCLI) is traded on NASDAQ Exchange in USA. It is located in 1325 Avenue of Americas and employs 43 people. Brainstorm Cell is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with current market capitalization of 104.84 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Brainstorm Cell's market, we take the total number of its shares issued and multiply it by Brainstorm Cell's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Brainstorm Cell conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 36.28 M outstanding shares of which 600.24 K shares are currently shorted by private and institutional investors with about 10.61 trading days to cover. Brainstorm Cell currently holds about 22.09 M in cash with (26.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.61.
Check Brainstorm Cell Probability Of Bankruptcy

Brainstorm Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Brainstorm Cell that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Brainstorm Cell's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Brainstorm Cell's value.
InstituionSecurity TypeTotal SharesValue
Vanguard Group IncCommon Shares1.4 M4.8 M
Blackrock IncCommon Shares474.5 K1.6 M
Susquehanna International Group LlpCall Options246.9 K830 K
Susquehanna International Group LlpPut Options165.7 K557 K
View Brainstorm Cell Diagnostics

Brainstorm Cell Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Brainstorm Cell market risk premium is the additional return an investor will receive from holding Brainstorm Cell long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Brainstorm Cell. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Brainstorm Cell's alpha and beta are two of the key measurements used to evaluate Brainstorm Cell's performance over the market, the standard measures of volatility play an important role as well.

Brainstorm Stock Against Markets

Picking the right benchmark for Brainstorm Cell stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Brainstorm Cell stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Brainstorm Cell is critical whether you are bullish or bearish towards Brainstorm Cell at a given time.
Brainstorm Cell cannot be verified against its exchange. It appears that Brainstorm Cell is not available for investing at the moment. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Brainstorm Cell stock to make a market-neutral strategy. Peer analysis of Brainstorm Cell could also be used in its relative valuation, which is a method of valuing Brainstorm Cell by comparing valuation metrics with similar companies.

Brainstorm Cell Corporate Directors

Brainstorm Cell corporate directors refer to members of a Brainstorm Cell board of directors. The board of directors generally takes responsibility for the Brainstorm Cell's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Brainstorm Cell's board members must vote for the resolution. The Brainstorm Cell board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Malcolm Taub - Independent DirectorProfile
Mordechai Friedman - Independent DirectorProfile
Anthony Polverino - Independent DirectorProfile
Chen Schor - Independent DirectorProfile

Investing Brainstorm Cell

You need to understand the risk of investing before taking a position in Brainstorm Cell. The danger of trading Brainstorm Cell is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Brainstorm Cell is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Brainstorm Cell. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Brainstorm Cell is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities. Note that the Brainstorm Cell information on this page should be used as a complementary analysis to other Brainstorm Cell's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Global Correlations module to find global opportunities by holding instruments from different markets.

Other Tools for Brainstorm Stock

When running Brainstorm Cell price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like